Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
lK.
a :
E-mail : kabradrugs@rediffmail.com
: www.kabradrugsltd.com
Website
Limited,
Phiroze Jeeieebhoy Towers, Dalal Street,
Mumbai - 400 001 (MH)
BSE
Reft Scrip
Code 524322
Sub: Outcome of Board Meeting 2/2OL6 -Unaudited Standalone Financial Results for
the quarter ended 30th June, with Limited Review Report.
Dear Sir/Madam,
In
Thanking you,
Yours faithfully,
FOR, KABRA DRUGS LI
t@
ANCHAL KABRA
COMPANY SECRETAR
Encl: As above
o RU
*
o
IK
A |
CIN : LO2423MP1989PLC005438
Part I
3 Months
ing
ended
CuffentPeriod
months
S. No.
ended
PARTICULARS
Notes Below
lJnaudited
30.06.2016
Audited
31.03.2016
301.18
0.98
245.06
0.10
965.45
t77.ll
302.L6
245.76
967.OA
tla.z2
240.55
0.00
793.25
0.00
727.43
0.00
0.00
163
1.10
14.21
66.16
33.39
0.99
27.86
5.76
37.86
25.47
L42.57
t7 4.00
307.02
239.57
962.17
3.11
-4.46
0.00
0.00
0.00
0.00
3.11
-4.46
5.65
4.91
0.00
0.00
0.00
0.00
(5+61
3.11
-4.46
5.65
4.9r
ExceDtlonal items
0.00
0.00
0.00
0.00
3.11
-4.46
5.65
4,9L
0.00
0.00
0.00
2.11
3.11
-4.86
5.65
2.7
0.00
0.00
0.00
0.00
3.11
0.00
0.00
-4.86
0.00
0.00
5.65
0.00
0.00
2.7
2.74
434.46
Proiii-Loss)
(7-Zl
4 0ther Income
5 Profr 7Oo-ss If romOrdinaryactivities
before finance costs and Exceptional ltems
(3+41
6 Finance Costs
7 Profit / (Loss) from ordinary activities after
linance costs but before exceptional ltems
B
Audited Unaudited
31.03.2016 30.06.2015
1.51
175.60
2 Expenses
(a) Cost ofmaterials consumed
(b) Purchase of Stock -in- Trade
(c) Change in inventories offinished goods,
work -in-progress and stock'in_tIade
(d) Employee benefits expense
(e) Depreciation and amortisatron expense
(f ) otler Expenses
Total exDenses
from operations before other
3
Income, Finance costs and Exceptional ltems
in
10 Tax expences
11 Net Profit/[Loss) from
rd
tz
associates
Paid up equity share capital
fFace value ofRs,10 each]
1B Resen es excluding Revaluation Reserves as
per Balance sheet ofprevious accounting
t7
1.97
14.66
5.7 6
24.31
4.91
3.11
-4.46
5.65
438.86
438.86
438,86
yeaf
]I
0.00
0.00
175.63
Drugs Ltd.,
Director.
IK
A : 0731-2971305, 6501305
: kabradrugs@rediffmail.com
Website : www.kabradrugsltd.com
E-mail
CIN : LO2423MP1989PLC005438
t9
(before Extraordinary
-0.11
0.13
0.05
o.o7
-0.11
0.13
0.06
fal Basic
0.07
-0.11
0.13
0.06
(b) Diluted
o.o7
-0.11
0.13
0.06
[a) Basic
(b) Diluted
ii. Earnine nershare {after extraordinarv
(ofRs.10 each) (not annualised)
1 The above results duly reviewed by Audit Committee, have been approved by the Board of
Directors in its meetingheld on 13th August,2016.
2 Previous year fiBures have been regrouped/rearranged wherever necessary
3 Statutory auditors ofthe companyhave carried out a limited reviewofabove result
Forand on
Plae : Indore
behalfofthe
rd
Date :13.08.2016
Ltd
RMAN AND
MANAGING
DIRECTOR
Din:0O76O020
Director.